Tom Gallen

Tom Gallen

Managing Editor, Europe

Birmingham, UK

Tom reports and edits European consumer health care industry news and analysis. Leading HBW Insight’s health and wellness coverage in Europe, he has been writing about the sector since 2013. Tom’s main focus is analyzing the strategies of the world's leading consumer healthcare companies, their business performance, plans and product portfolios. He also reports on regulatory topics such as novel foods and prescription-to-OTC switches.

Latest from Tom Gallen

Futura Sets Sights On Taking Eroxon To China

With the grant of a patent, Futura is hoping to take its Eroxon product to China, a country with a large population of ED sufferers, the firm claims.

Vision Healthcare Grows VMS Offering With Sweden’s BioSalma

Vision Healthcare adds an established supplements portfolio, alongside a robust omni-channel set-up across the Nordics, with the acquisition of BioSalma.

Venture Life Offloads Oral Care Assets To Focus on Power Brands

Covestus Holdings will pay £4.3m to acquire UK-based Venture Life’s oral care brands Ultradex and Dentyl.

Cooper And Dr Reddy’s Take Charge Of Nicotinell In Key European Markets

France, Spain and Belgium among countries where Cooper Consumer Health has launched NRT brand Nicotinell on behalf of Dr Reddy’s.

Reckitt Seizes OTC Growth Opportunity In Emerging Markets

Reckitt's leadership discussed the company's growth strategy for emerging markets at a recent meeting for analysts.

People On The Move: Appointments At Stada, Nestlé, CMA

A round-up of the latest people moves: Stada names general counsel; Nestlé announces departures; CMA elects board members.